Hemostasis Today

May, 2026
May 2026
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Mattia Galli: Is Clopidogrel Superior to Aspirin for Secondary Prevention in CCS?
May 28, 2026, 20:41

Mattia Galli: Is Clopidogrel Superior to Aspirin for Secondary Prevention in CCS?

Mattia Galli, Assistant Professor at Sapienza University of Rome, Associate Editor of European Heart Journal, shared on LinkedIn about a recent review and meta-analysis he and his colleagues co-authored, published in EuropeanHeartJournal, adding:

”Is clopidogrel superior to aspirin for secondary prevention in patients with CCS?

I had the privilege of contributing to these two recent papers published in the European Heart Journal, which help address many of the key questions surrounding this topic — while perhaps raising a few new ones along the way.”

Title 1: Aspirin or P2Y12 inhibitor monotherapy in atherosclerotic cardiovascular disease? Get access Arrow

Authors: Mattia Galli, Jurrien ten Berg, Marco Valgimigli, Davide Capodanno, Felice Gragnano, Takeshi Kimura, Deepak L Bhatt, C Michael Gibson, Roxana Mehran, Dominick J Angiolillo

Mattia Galli: Is Clopidogrel Superior to Aspirin for Secondary Prevention in CCS?

Title 2: Aspirin vs clopidogrel in chronic coronary syndromes: a meta-analysis of ethnic differences Get access Arrow

Authors: Claudio Laudani, Giovanni Occhipinti, Francesco Costa, Domenico D’Amario, Tullio Palmerini, Sebastiano Sciarretta, Charles Michael Gibson, Behnood Bikdeli, Felicita Andreotti, Young-Hoon Jeong, Takeshi Kimura, Diana A Gorog, Dirk Sibbing, Davide Capodanno, Jurrien ten Berg, Raffaele De Caterina, Mattia Galli

Mattia Galli: Is Clopidogrel Superior to Aspirin for Secondary Prevention in CCS?

Stay updated on all scientific advances with Hemostasis Today.